hematide: Clinical Trials

14 completed, 5 terminated. 11 Phase 2, 5 Phase 3, 2 Phase 1, 1 Phase 4.

By phase and status

Phase	Trials	Status
Phase 2	11	Completed 8, Terminated 3
Phase 3	5	Completed 5
Phase 1	2	Completed 1, Terminated 1
Phase 4	1	Terminated 1

Follow hematide: new trials by email Literature Review of hematide trials Research Report on hematide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Patients Receiving Hemodialysis Peginesatide, Epoetin alfa - Anemia	Phase 4	Terminated	Amgen	41	2012-10-01	2014-04-21
Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis Epoetin, Peginesatide - Chronic Kidney Disease, Anemia	Phase 3	Completed	Takeda	184	2011-10-01	2016-09-20
Efficacy and Safety of Peginesatide Injection for the Maintenance Treatment of Anemia in Peritoneal Dialysis Participants Previously Treated With Epoetin. Peginesatide - Anemia	Phase 2	Completed	Takeda	59	2008-10-01	2012-08-15
Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa. Peginesatide - Anemia	Phase 2	Completed	Takeda	102	2008-09-01	2012-07-27
Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESA peginesatide, Epoetin Alfa - Anemia, Chronic Renal Failure	Phase 2	Completed	Affymax	114	2008-06-01	2012-06-29
A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy. Peginesatide - Anemia	Phase 1	Terminated	Takeda	2	2008-01-01	2011-12-01
Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis peginesatide, Darbepoetin alfa - Chronic Renal Failure, Chronic Kidney Disease	Phase 3	Completed	Affymax	493	2007-11-01	2013-02-12
Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis peginesatide, Epoetin alfa or Epoetin beta - Chronic Renal Failure, Chronic Kidney Disease	Phase 3	Completed	Affymax	823	2007-10-01	2013-03-08
Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis peginesatide, Darbepoetin alfa - Chronic Renal Failure, Chronic Kidney Disease	Phase 3	Completed	Affymax	490	2007-10-01	2013-02-12
Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis peginesatide, Epoetin Alfa - Chronic Renal Failure, Chronic Kidney Disease	Phase 3	Completed	Affymax	803	2007-09-01	2013-02-12
Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis peginesatide - Anemia, Chronic Kidney Disease	Phase 2	Completed	Affymax	91	2006-12-01	2012-06-29
Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU) peginesatide - Chronic Renal Failure, Chronic Kidney Disease	Phase 2	Terminated	Affymax	114	2006-11-01	2012-06-29
Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD peginesatide - Chronic Renal Failure, Chronic Kidney Disease	Phase 2	Terminated	Affymax	81	2006-09-01	2012-06-29
Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney Disease Peginesatide - Anemia, Chronic Kidney Disease	Phase 2	Completed	Takeda	22	2006-04-06	2019-03-14
Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy peginesatide - Chemotherapy Induced Anemia, Cancer	Phase 2	Completed	Affymax	60	2006-01-01	2012-12-21
Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients peginesatide - Anemia, Chronic Kidney Disease	Phase 2	Completed	Affymax	139	2005-09-01	2012-12-21
Peginesatide for Anemia in Chronic Hemodialysis Patients peginesatide - Anemia, Chronic Kidney Disease	Phase 2	Completed	Affymax	165	2005-07-01	2012-12-21
Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease Placebo, peginesatide - Anemia, Chronic Kidney Disease	Phase 2	Terminated	Affymax	17	2005-03-01	2012-12-21
Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers Placebo, peginesatide - Anemia, Chronic Kidney Disease	Phase 1	Completed	Affymax	28	2004-08-01	2012-12-21

Conditions studied

Anemia (19)  ·  Kidney Failure, Chronic (15)  ·  Renal Insufficiency, Chronic (15)  ·  Neoplasms (2)  ·  Red-Cell Aplasia, Pure (1)  ·  Renal Insufficiency (1)

Sponsors

Affymax (13)  ·  Takeda (5)  ·  Amgen (1)

Countries

United States (11)  ·  United Kingdom (10)  ·  Poland (5)  ·  Bulgaria (4)  ·  Romania (4)  ·  Germany (3)  ·  Italy (3)  ·  Czechia (2)  ·  France (2)  ·  Puerto Rico (2)  ·  Australia (1)  ·  Hungary (1)  ·  New Zealand (1)  ·  Russia (1)  ·  Spain (1)

Top investigators

Vice President, Clinical Development (8)

Results publications

PMID 23343061, PMID 23343062, PMID 19890127, PMID 21940838, PMID 22935486

NIH funding

2005 (4), 2008 (2), 2004 (1)